首页> 外国专利> PHARMACEUTICAL COMPOSITION COMPRISING 4-(5-(4-NITROPHENYL)-1,2,4-OXADIAZOL-3-YL)-1,2,5-OXADIAZOL-3-AMINE FOR PREVENTING AND TREATING OF NEURODEGENERATIVE DISEASE

PHARMACEUTICAL COMPOSITION COMPRISING 4-(5-(4-NITROPHENYL)-1,2,4-OXADIAZOL-3-YL)-1,2,5-OXADIAZOL-3-AMINE FOR PREVENTING AND TREATING OF NEURODEGENERATIVE DISEASE

机译:包含4-(5-(4-硝基苯基)-1,2,4-恶二唑-3-基)-1,2,5-恶二唑-3-胺的药物组合物用于预防和治疗神经退行性疾病

摘要

PURPOSE: A pharmaceutical composition containing 4-(5-(4-nitrophenyl)-1,2,4-oxadiazol-3-yl)-1,2,5-oxadiazol-3-amine for preventing and treating neurodegenerative diseases is provided to specifically suppress S1 pocket of GFP II and to prevent and treat Alzheimer's disease. CONSTITUTION: A pharmaceutical composition for preventing and treating Alzheimer' diseases, Parkinson' disease, amylotrophic lateral scelerosis(ALS), or dementia contains 4-(5-(4-nitrophenyl)-1,2,4-oxadiazol-3-yl)-1,2,5-oxadiazol-3-amine of chemical formula 1 or a pharmaceutically acceptable salt thereof as an active ingredient. The compound of chemical formula 1 specifically suppresses a S1 pocket of GCP II(Glutamate Carboxypeptidase II). The compound of chemical formula 1 maintains homeostasis of intracellular amyloid beta(A beta).
机译:用途:提供包含4-(5-(4-硝基苯基)-1,2,4-恶二唑-3-基)-1,2,5-恶二唑-3-胺的药物组合物,用于预防和治疗神经退行性疾病。特异性抑制GFP II的S1囊袋并预防和治疗阿尔茨海默氏病。组成:用于预防和治疗阿尔茨海默氏病,帕金森氏病,肌萎缩性侧索性硬化症(ALS)或痴呆症的药物组合物,包含4-(5-(4-硝基苯基)-1,2,4-恶二唑-3-基)化学式1的-1,2,5-恶二唑-3-胺或其药学上可接受的盐作为活性成分。化学式1的化合物特异性抑制GCP II(谷氨酸羧肽酶II)的S1口袋。化学式1的化合物维持细胞内淀粉样蛋白β(A beta)的稳态。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号